Market study • Edition 2026
The immuno-oncology market in France
Market size, players, trends and sourced figures for your business plan, your bank file or your competitive analysis.
- The market: €4.6bn of reimbursed immunotherapies in 2024, inhibitors, CAR-T cells
- The players: Ipsen, ImCheck Therapeutics, Innate Pharma, AstraZeneca, Sanofi…
- The issues: market access, pricing and reimbursement, biotech partnerships
Exclusive sources: trade press with more than 500 journals and 3,000 new articles a month, not available in open access. Every cited article can be read.
The immuno-oncology market in France
€99 incl. VAT€93.84 excl. VAT
Request the study Read the study View the previewKey figures of the immuno-oncology market in France
The immuno-oncology market in France represents around €4.6bn in cancer immunotherapies reimbursed on the hospital add-on list (liste en sus) in 2024, based on a calculation using INCa data. It brings together treatments using immunity against cancer: checkpoint inhibitors, CAR-T cells, bispecific antibodies and therapeutic vaccines, with Ipsen, ImCheck Therapeutics and Innate Pharma. The number of patients treated with CAR-T cells rises by 49.5% in 2023, to 1,173.
- Cancer immunotherapies reimbursed on the add-on list (liste en sus) in hospitals
- €4.6bn
- 2024 • Source: Calculation based on the Institut national du cancer (INCa, the French national cancer institute)
- Cancer drugs on the add-on list, up 14.5% in one year
- €5.6bn
- 2024 • Source: INCa, Panorama des cancers 2026
- Patients treated with checkpoint inhibitors (+21% in one year)
- 90,466
- 2023 • Source: INCa, Panorama des cancers 2026
- Patients treated with CAR-T cells (+49.5% in one year)
- 1,173
- 2023 • Source: INCa, Panorama des cancers 2026
- New cancer cases in France
- 433,136
- 2023 • Source: INCa, Panorama des cancers 2026
- Paid by Ipsen for ImCheck Therapeutics, up to €1bn with milestones
- €350m
- October 2025 • Source: Ipsen, press release of 22 October 2025
The immuno-oncology market in France in 5 questions
Our analysts’ answers, taken from the study. The full analysis, the charts and the detailed sources are in the report.
How big is the immuno-oncology market in France?
How many patients are treated with cancer immunotherapy in France?
Who are the main players in immuno-oncology in France?
How do French immuno-oncology biotechs get funded?
How are cancer immunotherapies reimbursed in France?
Sources: Institut national du cancer, Panorama des cancers en France, 2026 edition • Institut national du cancer, Panorama des cancers en France, 2024 edition • Ipsen, press release of 22 October 2025 • Le Journal des entreprises, November 2024, January and February 2026 • Pharmaceutiques, March 2026 • Trade press (IndexPresse database)


Browse an excerpt before you buy
A free excerpt of the study: judge the writing, the figures and the sources for yourself.
In the preview
- The purpose of the study and its key figures
- The complete table of contents
- The layout of the charts and sources
Study contents
Browse the chapters to identify the analyses relevant to your project.
- Understand customers and uses
- Connect products, businesses and distribution channels
- Compare market participants and their models
1. Immuno-oncology and its scope
2. Market size and dynamics
3. Patients and medical needs
4. Pharmaceutical companies and biotechs
5. Market access and reimbursement
6. Outlook for immuno-oncology
Why a Businesscoot study
Three ways to answer the same question about a market, compared line by line.
| General-purpose AIA draft to verify | Traditional research firmThorough, but costly | Businesscoot studyComplete and affordable |
|---|---|---|
| FiguresCited links, variable reliability | FiguresOwn sources and estimates | FiguresSource and period for every figure |
| Professional pressOutside the public web | Professional pressVaries by firm | Professional press500+ paid journalsIndexPresse database |
| ScopeTo restate with every question | ScopeDefined | ScopeFrench market, clearly bounded |
| ContentGeneral answers, to cross-check | ContentTailored to the brief | ContentSize, players, trends, forecasts |
| DeliverableText to format | Deliverable150 to 300 pages | DeliverableStructured file with charts |
| Your timeInstant answer | Your timeLong to digest | Your timeReady to read |
| CostFree or subscription | CostAbout €1,000 to €3,000 excl. VAT | Cost€99 incl. VAT |
General-purpose AI
A draft to verify
- Figures
- Cited links, variable reliability
- Professional press
- Outside the public web
- Scope
- To restate with every question
- Content
- General answers, to cross-check
- Deliverable
- Text to format
- Your time
- Instant answer
- Cost
- Free or subscription
Traditional research firm
Thorough, but costly
- Figures
- Own sources and estimates
- Professional press
- Varies by firm
- Scope
- Defined
- Content
- Tailored to the brief
- Deliverable
- 150 to 300 pages
- Your time
- Long to digest
- Cost
- About €1,000 to €3,000 excl. VAT
Businesscoot study
Complete and affordable
- Figures
- Source and period for every figure
- Professional press
- 500+ paid journalsIndexPresse database
- Scope
- French market, clearly bounded
- Content
- Size, players, trends, forecasts
- Deliverable
- Structured file with charts
- Your time
- Ready to read
- Cost
- €99 incl. VAT
They bought our studies
Reviews collected after purchase and published as written, in French.
- studies sold since 2009
- 43,000+
- customers trust us
- 21,000+
- of market studies
- 17 years
- of IndexPresse press
- 35 years
« Etude pertinente avec un rapport qualité prix absolument imbattable. Idéal pour dossier bancaire ou rachat de société. Je recommande. »Mathieu Petit • Agence Felix
Le marché du karting
« Ces études de marché sont une très bonne synthèse pour tout professionnel qui souhaite gagner du temps. »
Paul Grasset
Le marché du linge de maison
« Etude claire, synthétique et bien structurée (agréable à lire et facile à en tirer la substance souhaitée). »
Sébastien Menand
Le marché du thé
« Étude de marché très précise et documentée, notamment sur les sous-segments de ce marché. »
Jean-Philippe Aboab • Pharmefficare
Le marché de la garde d’enfants
How the study is built
In-house analysts, professional sources and figures checked against their original publication.
- 17 years of market studies
- 35 years of professional press
- Sources you can open
01
Define
The market is defined before it is measured: products, channels, geographic area. Every figure covers that same scope.
02
Source
Public statistics, professional bodies and more than 500 paid trade journals from the IndexPresse database.
03
Cross-check
Every figure is matched with its original publication and dated. From the study, you can trace each one back to its source.
04
Update
When you order, one of our analysts updates the study with the latest published figures. You receive it within 48 hours.

Guilhem Cournut
Food, retail and consumer goods

Denis Monnoyeur
Industry, energy and construction

Marie-Annick Cournède
Health, beauty and personal services

Arthur Lefeuvre
Digital, media and telecommunications
Frequently asked questions
Quick answers about the market, the study and your order.
How big is the immuno-oncology market in France?
What does the study contain and in what format?
What sources does the study draw on?
Is the data up to date?
Who is this study for?
When and how will I receive the study?
How is it different from a Google search or an AI?
Can I get an invoice, pay by bank transfer or ask for a quote?
What if the study does not match what is announced?
I need several studies: is there a better price?
Order the study
This study
Updated for 2026The immuno-oncology market in France
€99incl. VAT • €93.84 excl. VAT
- PDF, 34 figures and 41 pages, 2026 edition
- Updated when you order, sent by email
- Invoice with VAT
- 4.5/5 from 827 reviews



Several markets to study
The 3-study pack
€240incl. VAT • €80 per study
The 5-study pack
€350incl. VAT • €70 per study
The Businesscoot subscription
On quoteunlimited access
- 3 studies of your choice in the catalogue
- To use within 12 months
- No subscription or renewal
- One invoice with VAT
- 5 studies of your choice in the catalogue
- To use within 12 months
- No subscription or renewal
- One invoice with VAT
- Every study in the catalogue, unlimited
- Price and term set on quote
- A talk with the team before any commitment
- One invoice with VAT
Related studies
Explore complementary studies to broaden your analysis.
- Explore related markets
- Compare market dynamics
- Refine your project
The oncology market in France
Anticancer drugs cost €9.6bn in France in 2023, 3.5 times more than in 2012, driven by immunotherapy and targeted therapies.
The general practitioners and specialist doctors market in France
In 2025, community care by general practitioners and specialists reaches €23.9bn in France, while 47% of practising doctors are salaried.
The mental health market in France
In 2024, the French health insurance system (Assurance maladie) reimbursed €29.1bn for psychiatric illness and psychotropic drugs, or 13.7% of its spending.
See also: The pain management market in France • The hydroponics market in France • The contract clinical research market in France • The medically assisted reproduction market in France • France gene therapy market



